234,844 Shares in Cigna Group $CI Acquired by Korea Investment CORP

Korea Investment CORP acquired a new stake in Cigna Group (NYSE:CIFree Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 234,844 shares of the health services provider’s stock, valued at approximately $64,742,000.

A number of other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Cigna Group during the 4th quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its stake in Cigna Group by 13,333.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the last quarter. Dodge & Cox increased its holdings in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares in the last quarter. Boston Partners raised its position in Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after acquiring an additional 1,243,056 shares during the last quarter. Finally, GQG Partners LLC raised its position in Cigna Group by 14.3% during the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after acquiring an additional 972,302 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on CI shares. Guggenheim increased their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Wolfe Research reaffirmed an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a research note on Tuesday, June 16th. Robert W. Baird set a $362.00 target price on Cigna Group in a report on Friday, July 31st. Finally, Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Read Our Latest Research Report on Cigna Group

Cigna Group Stock Up 0.6%

CI stock opened at $276.19 on Friday. The stock has a market capitalization of $72.98 billion, a P/E ratio of 11.43, a PEG ratio of 0.94 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The company has a 50 day moving average price of $284.20 and a two-hundred day moving average price of $281.38.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the company posted $7.20 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.